A good critical-to-quality workshop identifies the handful of factors that truly determine participant safety and the reliability of results, then changes the protocol and the oversight plan to protect them. If the protocol looks the same afterward, the workshop was a compliance exercise rather than quality by design.
ICH E6(R3) builds on the quality-by-design principles of ICH E8(R1) and asks sponsors to identify critical-to-quality factors prospectively. Most sponsors agree with the idea. Fewer run the conversation in a way that produces real decisions.
What are critical-to-quality factors?
They are the attributes of a trial whose integrity is fundamental to protecting participants and producing reliable results. Common examples include the eligibility criteria that define the population, the assessment of the primary endpoint, investigational product dosing and administration, informed consent, key safety assessments, and randomization and blinding.
Who should be in the room?
Clinical science and medical, biostatistics, clinical operations, data management, regulatory, safety and quality. If possible, include an investigator or study coordinator perspective, and consider the participant's view. If your CRO has been selected, bring its study lead. Different functions see different risks, and that is the point.
How should the workshop be structured?
Prepare. Circulate the draft protocol synopsis, lessons from earlier studies and an initial risk inventory.
Identify what matters. For the primary objective and participant safety, ask what must go right.
Identify threats. For each critical factor, ask what could go wrong and how likely, impactful and detectable each threat is.
Simplify. Challenge procedures and data that do not serve the objectives. Every extra assessment adds burden and risk.
Decide controls. Design changes, training, targeted monitoring, centralized checks and quality tolerance limits.
Document. Record the critical factors, the rationale and how each links to the monitoring plan, data management plan and risk register.
What should change as a result?
Typical outcomes include simplified eligibility criteria, fewer exploratory endpoints, standardized training for endpoint assessors, central reading of key assessments, a clearer consent process and a monitoring plan focused on the data that matter most. If none of that changes, ask why.
Expect some productive tension in the room. A medical lead may want an extra exploratory endpoint, a clinical operations lead may see the site burden it creates and a statistician may question whether it can be analyzed at all. That debate is the workshop doing its job. Record the trade-off and the decision, so the rationale survives into the protocol and beyond.
How do you keep critical-to-quality thinking alive?
Revisit the list at each amendment, after the first sites enroll and at interim milestones. Connect your key risk indicators directly to the critical factors, so governance discussions stay focused on what protects participants and results rather than on everything that can be counted.
Keep reading: KPIs Tell You What Happened. KRIs Tell You What's Coming.
